Analysis of the real-world overdose risks associated with gabapentin makes the cut for the JAMA Most Read list.
Matthew Ellis PhD and Kevin Xu MD MPH Publish Research on Gabapentin in JAMA Psychiatry
View Content
Analysis of the real-world overdose risks associated with gabapentin makes the cut for the JAMA Most Read list.